World News – CA – Emergency COVID-19 Antibody Treatment Approved in Canada


. .

Eli Lilly and Co received the green light to distribute bamlanivimab for the treatment of patients 12 years and older with mild to moderate COVID-19 infections Friday, according to the Health Canada website.

Treatment is for people who are at risk of developing severe COVID-19 symptoms or being hospitalized – not for those who are already in the hospital or need oxygen.

According to CTV News, Lilly expects to manufacture up to a million cans for global use by the end of 2020.

Bamlanivimab is the first monoclonal antibody approved for the treatment of coronavirus and has been approved for emergency use by the Food and Drug Administration in the United States. S.. . beginning of November.

According to the publication, bamlanivimab is said to block virus attachment and entry into human cells to neutralize the virus and potentially treat COVID-19.

Lilly scientists developed the treatment in less than three months after AbCellera discovered the antibody in a blood sample from one of the first U’s. S.. . Patients to recover from the virus

1640 Ouellette Avenue



N8X 1L1

Studio / Contest Lines

News tips

newscentre @ am800cklw. com

299 Queen Street West



M5V 2Z5

iHeartRadio Terms and Conditions

iHeartRadio privacy policy

Contact us

Political Advertisement Register

Eli Lilly and Company, Antibodies, Monoclonal Antibody Therapy, Emergency Approval, Health Canada

World News – CA – Emergency COVID-19 Antibody Treatment Approved in Canada



Abonnez-vous à notre chaîne Youtube en cliquant ici: EBENE MEDIA TV

Vidéo du jour:

Donnez votre point de vue et aboonez-vous!


Votre point de vue compte, donnez votre avis

[maxbutton id= »1″]